Drugs / BTA9881
BTA9881
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00504907 | Jul 2007 → Dec 2008 | respiratory syncytial virus infectious disease | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BTA9881 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00504907 ↗ |
| Known as | AZD-9639 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3393588 ↗ |
| Known as | MEDI-564 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3393588 ↗ |
| Modality | Small molecule | — CHEMBL3393588 ↗ |
| Route | Oral | “BTA9881 administered orally” NCT00504907 ↗ |